InflaRx Will Focus Development Activities And Resources Initially On Selected Indications In Immuno-dermatology, With Registrational-phase Vilobelimab And INF904
InflarX 最初将开发活动和资源集中在免疫皮肤病学的特定适应症上,包括注册阶段 Vilobelimab 和 INF904
InflaRx Will Focus Development Activities And Resources Initially On Selected Indications In Immuno-dermatology, With Registrational-phase Vilobelimab And INF904
InflarX 最初将开发活动和资源集中在免疫皮肤病学的特定适应症上,包括注册阶段 Vilobelimab 和 INF904
使用浏览器的分享功能,分享给你的好友吧